Natera, Inc. (NTRA)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Natera, Inc. (NTRA)
Go deeper and ask any question about NTRA
Company Performance
Current Price
as of Sep 13, 2024$126.51
P/E Ratio
N/A
Market Cap
$15.65B
Description
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.
Metrics
Overview
- HQAustin, TX
- SectorHealth Technology
- IndustryMedical Specialties
- TickerNTRA
- Price$126.51+1.11%
Trading Information
- Market Cap$15.65B
- Float93.97%
- Average Daily Volume (1m)1,174,206
- Average Daily Volume (3m)1,423,948
- EPS-$2.47
Company
- Revenue$1.36B
- Rev Growth (1yr)58.13%
- Net Income-$37.46M
- Gross Margin58.83%
- EBITDA Margin-8.71%
- EBITDA-$35.99M
- EV$12.85B
- EV/Revenue9.45
- P/EN/A
- P/S11.42
Documents
SEC Filings
Earnings Calls